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Protein phosphatase 5 (Ppp5) is one of several pro-
teins that bind to the Hsp90 chaperone via a tetratri-
copeptide repeat (TPR) domain. We report the solution
structure of a complex of the TPR domain of Ppp5 with
the C-terminal pentapeptide of Hsp90. This structure
has the ‘‘two-carboxylate clamp’’ mechanism of pep-
tide binding first seen in the Hop-TPR domain com-
plexes with Hsp90 and Hsp70 peptides. However,
NMR data reveal that the Ppp5 clamp is highly dy-
namic, and that there are multiple modes of peptide
binding and mobility throughout the complex. Al-
though this interaction is of very high affinity, rela-
tively few persistent contacts are found between the
peptide and the Ppp5-TPR domain, thus explaining
its promiscuity in binding both Hsp70 and Hsp90
in vivo. We consider the possible implications of this
dynamic structure for the mechanism of relief of auto-
inhibition in Ppp5 and for the mechanisms of TPR-
mediated recognition of Hsp90 by other proteins.
Introduction
Numerous cellular functions and signal transduction
pathways are regulated through a complex system of
reversible phosphorylation of the serine, threonine, or
tyrosine residues of proteins. Protein kinases and phos-
phatases, the enzymes responsible for phosphorylation
and dephosphorylation, respectively, are themselves
tightly controlled by modulation of their activity, and
by their specificity for and targeting to their substrates.
Protein phosphatase 5 (Ppp5) is a ubiquitous member
of the PPP family of serine/threonine phosphatases
(Chinkers, 2001). Ppp5 consists of a C-terminal catalytic
domain, whose architecture is conserved throughout
the family, connected by a flexible linker to an N-terminal
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S10 2TN, United Kingdom.tetratricopeptide repeat (TPR) domain. The presence of
a TPR domain is unique among members of the PPP
family, and it has been found to be essential for the reg-
ulation of Ppp5’s phosphatase activity (Chen and Co-
hen, 1997; Sinclair et al., 1999). The Ppp5-TPR domain
also targets the phosphatase to the 90 kDa heat shock
(Hsp90) chaperone complex, where it binds a conserved
sequence at the C terminus of Hsp90 (Chen et al., 1996;
Prodromou et al., 1999). Hsp90 is an essential molecular
chaperone that is responsible for the activation or mat-
uration of many key proteins of signal transduction path-
ways, including steroid hormone receptors, helix-loop-
helix transcription factors, and tyrosine/threonine and
serine/threonine kinases (Richter and Buchner, 2001;
Pratt and Toft, 2003). In fulfilling its role, Hsp90 interacts
with cochaperone proteins that either help to deliver the
substrate protein to the complex or to regulate the con-
formation and activity of the substrate or Hsp90 itself.
A substantial number of these cochaperones bind to
the C terminus of Hsp90 through TPR domains (Young
et al., 2003). Amongst the best characterized TPR
domain-containing cochaperones are those involved in
the interaction of Hsp90 with the Hsp70 complex (Hop-
Hsp90 organizing protein; Chen and Smith, 1998), and
those that recruit particular enzymatic activities to the
complex, e.g., proline isomerases (FKBPs, Cyp40;
OwensGrillo et al., 1996), a ubiquitin E3 ligase (CHIP;
Connell et al., 2001), and a protein phosphatase (Ppp5;
Chen et al., 1996). Ppp5 has been shown to be important
in the maturation of glucocorticoid hormone receptors
(Zuo et al., 1999), and in the regulation of kinases, e.g.,
the haem-regulated inhibitor of protein synthesis,
eIF2a kinase (Shao et al., 2002), and transcription fac-
tors, e.g., heat shock factor 1 (Conde et al., 2005).
TPR domains are common mediators of protein-
protein interactions found in genomes from all kingdoms
of life, including more than 100 human examples
(D’Andrea and Regan, 2003). Many, and most of the
well-studied, functional TPR domains contain 3.5 tetra-
tricopeptide repeats. The first crystal structure of such
a domain to be determined was that of the TPR domain
from Ppp5 (Das et al., 1998). This and all subsequently
determined TPR domain structures show that each re-
peat can form a helix-turn-helix motif. These motifs are
usually arranged so that the pairs of helices stack
upon each other with a slight rotation between each
pair, resulting in a superhelical tertiary structure. The fi-
nal half-repeat is critical for stability, forming an addi-
tional helix that packs against the third repeat (Main
et al., 2003). Many of the residues conserved between
Hsp90 binding TPR domains are found on the concave
surface of the superhelix, and their mutation results in
loss of binding to Hsp90 (Russell et al., 1999). The crystal
structures of two of the Hop-TPR domains (Scheufler
et al., 2000) show Hsp90 and Hsp70 C-terminal peptides
bound at this surface. The C termini of both Hsp70 and
Hsp90 are very similar, being IEEVD and MEEVD, re-
spectively, and the most conserved residues of the
Hop domains were found to form a positively charged
‘‘clamp’’ that holds the two carboxylate groups of the
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416final aspartate. The Hop domains TPR1 and TPR2A spe-
cifically recognize Hsp70 and Hsp90, respectively, via
additional contacts between side chains on the concave
face of the domain with upstream residues of the chap-
erones’ C termini. The crystal structure of the E3 ubiqui-
tin ligase CHIP, which can bind Hsp90 or Hsp70, shows
that its TPR domain also binds the C-terminal aspartate
of the Hsp90 peptide via this clamp mechanism, al-
though the conformation of the peptide differs signifi-
cantly from that in Hop-TPR2A (Zhang et al., 2005).
The structure of FKBP52 also shows the Hsp90 peptide
at this concave surface, but the detail of the interaction
is unclear due to the low resolution of the data and
disorder within the crystal (Wu et al., 2004). No other
TPR domain structures have been solved bound to an
Hsp90 peptide; however, in the structure of the Ppp5
TPR domain (Das et al., 1998), and that of one crystal
form of Cyp40 (Taylor et al., 2001), the C terminus of
an adjacent molecule in the crystal is ‘‘bound’’ at this
site. It may be that interactions with a negatively
charged ligand are necessary to stabilize the superheli-
cal form of some of these TPR domains. In support of
this idea, biophysical studies of the isolated Ppp5-TPR
domain have shown that it is substantially unfolded at
physiological temperatures, and that it becomes fully
folded upon binding to a peptide derived from the
Hsp90 C terminus (Cliff et al., 2005).
Full-length Ppp5 has a very low activity against sub-
strate, but it is activated if the TPR domain is cleaved
from the protein or mutated at specific sites (Chen and
Cohen 1997; Sinclair et al., 1999; Kang et al., 2001) or
in the presence of activators that are known to bind to
the TPR domain, e.g., Hsp90 or arachidonyl CoA (Ram-
sey and Chinkers, 2002; Yang et al., 2005). The recently
solved crystal structure of the autoinhibited form of
Ppp5 reveals that a glutamate (E76) in the second TPR
motif, which had previously been implicated in this auto-
inhibition (Kang et al., 2001), makes contacts in the cat-
alytic site of the phosphatase domain in a manner anal-
ogous to several of the inhibitors of PP1 and to the
autoinhibition of PP2B (Yang et al., 2005). In this crystal
structure, the TPR domain also adopts the canonical su-
perhelical architecture, and, apart from the position of
the seventh helix, it superimposes well on the crystal
structures of the Ppp5-TPR domain itself and the pep-
tide bound structures from the homologous domains
from Hop. This superposition revealed that the autoinhi-
bitory interface formed between the phosphatase and
TPR domains partly overlaps the site of Hsp90 peptide
binding found for the Hop complex. Consequently, it
was hypothesized that the increase in activity upon ad-
dition of Hsp90, or a peptide containing the conserved
EEVD terminal sequence, results from direct competi-
tion for the Hsp90 binding site (Yang et al., 2005).
A complete understanding of molecular recognition
processes requires study in solution as well as by crys-
tallography. Here, we present studies of the wild-type
Ppp5-TPR domain and the solution structure and dy-
namics of a single point mutant (G83N) in complex
with the MEEVD peptide corresponding to the Hsp90 C
terminus. This is the first TPR domain structure bound
to a cognate ligand to be determined in solution. It con-
firms the consensus superhelical structure for the pep-
tide bound domain. The Hsp90 peptide recognitionmechanism utilizes the ‘‘clamp’’ first observed in the
Hop complexes, but it is otherwise distinct, lacking con-
tacts that could distinguish between Hsp90 and Hsp70,
and showing that the binding site and peptide-ligand
have multiple conformations in dynamic exchange on
timescales in the microsecond to millisecond range.
These structural and dynamic observations can be un-
derstood in light of the limited sequence conservation
in the Hsp90 binding sites of different TPR domains.
The structure of the Ppp5-TPR/peptide complex and
the flexibility of the recognition mechanism suggest an
allosteric mechanism for activation of the phosphatase,
rather than the direct competition deduced from the ear-
lier model based on the Hop structure.
Results and Discussion
The structural and dynamic properties of the TPR do-
main from Ppp5 were analyzed by using protein con-
structs comprised of residues 19–147 of human Ppp5,
which contains 3.5 tetratricopeptide repeats and all
the residues thought to be important for binding. Resi-
due 147 is the most C-terminal residue of the N-terminal
region of Ppp5 to have a helical conformation in the
structure of its autoinhibited conformation (Yang et al.,
2005). The peptide used in these studies corresponds
to the five C-terminal residues from Hsp90 (MEEVD)
that are necessary for binding (Ramsey et al., 2000). Ca-
lorimetric and CD measurements show that the peptide
binds with high affinity to this domain (Kd,obs w50 nM;
Cliff et al., 2005).
The Peptide Bound TPR Domain Contains Seven
Helices, but Is Locally Disordered
The wild-type Ppp5-TPR domain/Hsp90 peptide com-
plex was found to have substantially poorer signal inten-
sity than typical of a protein of 16.3 kDa, and it was
necessary to use a perdeuterated (2H13C15N-labeled)
protein sample to obtain backbone resonance assign-
ments (w95% complete excluding His tag). The second-
ary structure predicted from the 13C chemical shift
patterns of the assigned residues is in accord with the
canonical structure of seven helices (Figure 1B). How-
ever, a region of unassigned amides lies between resi-
dues 80 and 85, which would have been anticipated to
be the beginning of the fourth helix. Peaks correspond-
ing to residues on either side of this region also had rel-
atively low intensity, suggesting that a large part of this
helix is undergoing conformational exchange. Residues
in the C-terminal part of the seventh helix have two sets
of signals in slow exchange, which chemical shift evi-
dence and signal intensity show to arise from a majority
(>85%) helical conformation and a minority extended
and flexible conformation. The backbone amide reso-
nances of R113 and A114, which form the part of the
sixth helix that packs against this C-terminal region,
are also missing from the spectrum.
The triple resonance spectra contained two sets of
signals with identical Ca chemical shifts at different
1H,15N frequencies, which did not correspond with any
visible peak in the 1H15N-HSQC. Although these signals
could not be connected sequentially, a process of elim-
ination revealed that they arise from a single glycine res-
idue (G83) in slow-to-intermediate exchange between
Hsp90 Recognition by the Ppp5-TPR Domain
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fourth helix appears to be perturbed by the presence
of this glycine. This region is particularly important to
the stability of the TPR domain fold as it contains resi-
dues that impact on its conserved salt bridges. An
analysis of coevolved networks of interacting residues
(Magliery and Regan, 2004) has identified two major
subclasses of the TPR motif that are distinguished on
the basis of a characteristic residue at position 7 of the
repeat (either a positive or a hydrophobic residue). The
second and third repeats of Ppp5-TPR have arginine
at this position (R68 and R102). These arginines stabilize
the intrarepeat helix-helix interface by forming con-
served salt bridges to an aspartate residue at position
23 of the repeat (D84 or D118). Conformational variation
of residues neighboring G83 impacts on both of these
structural salt bridges. Specifically, D84 is the acceptor
of the conserved salt bridge in the second repeat, and
L82 packs against the aliphatic part of R102, which is
normally buried in the interface between the second
and third repeats. Given the potential for disruption of
these important interactions, it seemed possible that
Figure 1. Stabilization of the Canonical TPR Fold by a G83N Muta-
tion
(A) 1H15N-HSQC spectra of wild-type (red) and G83N (black) Ppp5-
TPR domains bound to an MEEVD peptide. Arrows highlight the
two C-terminal conformations of the wild-type domain.
(B) Extent of backbone assignment and the predicted wild-type and
actual mutant secondary structures of the complexes. The helical
structure in red is common to both native and mutant. The helical
structure in black is found only in the mutant. Residues of the se-
quence unassigned in the wild-type are in orange, and residues of
the sequence unassigned in both wild-type and mutant are in red.the conformational variation of the fourth helix could
be transmitted through the structure and explain the
atypical spectral features. Because G83 lies in a sol-
vent-exposed position on the opposite face of the TPR
domain from the anticipated Hsp90 binding site, and al-
though present in mammalian Ppp5 sequences is not
conserved among more distant species, it seemed
a good candidate for mutation aimed at improving spec-
tral quality.
A G83N Mutation Stabilizes the Canonical TPR
Domain Fold for the Complex
A G83N mutation was found to greatly improve the qual-
ity of the spectra obtained from the complex. The 1H15N-
HSQC spectrum and that of the wild-type domain over-
lay almost exactly (Figure 1A), except that the spectrum
of the mutant domain has more uniform linewidths,
a better signal-to-noise ratio, and several new peaks.
The new peaks include the amides of residues 80–85,
113, and 114. As the N-terminal part of the final helix in
the mutant has only one set of peaks that correspond
to the folded form in the native spectrum, it appears
that the effect of the mutation is to stabilize the major
conformation of the native sequence. Our assumption
in further studying the peptide bound form of this
G83N mutant is that it is a good model of the major con-
formation of the wild-type domain and that the proper-
ties of the wild-type domain could be obtained, in princi-
ple, by superimposing an additional slow-intermediate
conformational change onto the properties of the mu-
tant. In particular, in so far as can be determined from
comparison of the spectra, the chemical shifts of the
binding site residues are not affected by the mutation.
Furthermore, analysis of the binding thermodynamics
shows that the mutation affects only the stability of the
domain and that, when this stabilization effect is decon-
volved, the protein-peptide interactions themselves
give the same enthalpic and entropic contributions to
the intrinsic binding affinity in both wild-type and mutant
domains (Cliff et al., 2005).
Improved spectral quality enabled the assignment of
>95% of the side chain resonances of the mutant do-
main, together with a large number of NOEs from both
15N- and 13C-edited NOESY spectra. Structure calcula-
tions with restraints derived from NOEs, hydrogen ex-
change data, and chemical shift analysis produce
a well-defined ensemble for the G83N domain/peptide
complex (Table 1) with a consistent conformation for
the domain backbone and the majority of buried hydro-
phobic side chains (Figure 2A). The structures have the
canonical TPR domain fold, consisting of a superhelical
arrangement of helix-turn-helix repeats (Figure 2B). The
representative structure from the ensemble superim-
poses with a backbone rmsd < 1 A˚ on the ‘‘apo’’-TPR do-
main crystal structure (which was not bound to peptide,
but was interacting with a neigboring molecule at the
Hsp90 binding site; Das et al., 1998) and the peptide
bound Hop-TPR2A domain (Scheufler et al., 2000). The
position of the seventh helix is, however, distinctly dif-
ferent from that in the structure of the autoinhibited
form of Ppp5, being rotated byw6º and shifted by 4 A˚.
This difference in conformation is accompanied by ex-
tensive changes in side chain-side chain contacts
made between the final three helices.
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‘‘Two-Carboxylate Clamp’’
The peptide binds at the same site as that observed in
the homologous TPR2A domain from Hop (Figure 3A).
In particular, NOEs show interaction between the C-ter-
minal aspartate of the peptide (D0) and I63. The equiva-
lent residue in Hop (T280; Figure 6) interacts via its
methyl group with the aliphatic part of D0. There are
also NOEs between the protein residues N36, D37,
L70, and the valine (V-1) of the peptide. Consequently,
in the majority of its conformations, the V-1 side chain
is positioned in a hydrophobic pocket close to F39 and
L70, in a similar location to that found for the Hop com-
plex. The peptide orientation is such that, despite the
lack of observable NOEs, the C-terminal aspartate is po-
sitioned so as to make salt bridges to the essential con-
served lysines at positions 32 and 97 (Russell et al.,
1999; Ramsey et al., 2000), and a hydrogen bond be-
tween its backbone amide and N36, in the manner of
the ‘‘two-carboxylate clamp’’ first seen in the Hop struc-
ture. The conserved residues N36 and R101 are also
close to D0 and the backbone of V-1, although they do
not have a consistent hydrogen bonding pattern. The
two C-terminal residues of the peptide (VD) are found
predominately in the a-helical region of the Ramachan-
dran map, and their conformation is moderately well de-
fined (their internal heavy-atom rmsd isw2 A˚), although
their orientation with respect to the TPR domain is more






Short-range (i/ i + 2 2 4) 1002
Long-range (i/ i + >4) 1499
Ambiguous NOEs 858
To peptide (ambiguous and unambiguous) 10
Restraints per residue 66.8 6 31.2
Other
H bonds 94
Dihedrals (from TALOS) 219
Quality Assessment
Number of structures 19/100
Rmsd
2º structure only: backbone 0.42 6 0.09 A˚
Heavy atoms 0.80 6 0.11 A˚
Excluding ligand: backbone 0.54 6 0.20 A˚
Heavy atoms 0.74 6 0.40 A˚
Violations
Distances: > 0.5 A˚ 0
Distances: > 0.3 A˚ 1.8 6 1.4
Distances: > 0.1 A˚ 58.6 6 5.4







a Procheck analysis (Laskowski et al., 1993).
b Aquacompl analysis, excluding intraresidue NOEs (Doreleijers
et al., 1999).varied (rmsd = w2.5 A˚). The upstream residues (MEE)
have no NOEs to the protein, and the structures show
them to have no preferred location in the Ramachan-
dran; consequently, they become progressively more
positionally disordered in the N-terminal direction.
It is notable that no resonances for the side chain of
N67 could be found, and that several of the side chain
resonances of N36, K40, R68, K97, and R101 are also un-
assigned. These signals are assumed to be missing from
the 1H13C-HSQC spectra. This assumption is supported
by the absence of side chain NH signals for N36, N67,
and R101, and by the absence of the amide peaks for
R101 and R102 from the 1H15N-HSQC. These missing
resonances correspond to residues in or near the pep-
tide binding site (Figure 3B), including four of the con-
served residues from the clamp. This loss of signals is
consistent with the binding site side chains interchang-
ing between multiple conformations, possibly alternate
hydrogen bonding patterns, on the microsecond to mil-
lisecond timescale. The result is that the resonances are
so broad as to lie below the detection threshold.
Figure 2. Solution Structure of the Ppp5-TPR Domain/Hsp90 Pep-
tide Complex
(A) The superposition of the calculated structure ensemble; the
G83N-Ppp5-TPR domain is shown in black, and the Hsp90 penta-
peptide is shown in red.
(B) Cartoon representation of the representative structure from the
ensemble; the peptide-ligand is shown as a stick model.
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Motions on Multiple Timescales
Heteronuclear 1H15N-NOE (HNOE) data indicate the ex-
tent of motion of backbone amides on the nanosecond
timescale. The data for Ppp5-TPR show typical values
for the first five helices of the domain, with a slightly
greater than average mobility of the sixth and seventh
helices, together with the expected large increase in
mobility at the N and C termini (Figure 4A). Some amides
toward the middle of the helices within the second tetra-
tricopeptide repeat have motions that are greater than
average (e.g., residues 69 and 84) on this timescale.
Large amplitude, nanosecond timescale motion is also
indicated for A103, in the fifth helix. Motions on a micro-
second to millisecond timescale cause broadening of
resonances, with greater linewidths resulting from
greater variation in local environment (high-amplitude
motions) or slower motions. Fitting lineshapes in the
Figure 3. Structural and Dynamic Features of the Hsp90 Peptide
Binding Site
(A) Conserved polar two-carboxylate clamp residues are shown in
purple; additional residues consistently involved in ligand binding
are shown in pale blue. Residues that are physically distinct between
Hop and Ppp5 and whose variation is responsible for the different
binding modes of the Hsp90 peptide between those complexes
are shown in gray.
(B) Extent of side chain assignment shown on the surface of the TPR
domain (rotated 90º with respect to [A]). Unassigned resonances are
shown in red, assigned resonances are shown in green, and the pep-
tide is shown as a stick model. The absence of side chain resonances
from the spectra suggests that the affected chemical groups are un-
dergoing significant microsecond to millisecond timescale motion.1H15N-HSQC allows for visualization of the relative
extent of the effects of motions on this timescale (Fig-
ure 4B). Again, the backbone of the second tetratrico-
peptide repeat is particularly mobile, as are the residues
between 100 and 104. The clustering of these enhanced
motions on the nanosecond to millisecond timescales
around the conserved peptide binding residues N67
and R101, whose side chains signals have broadened
beyond detection, strongly suggests that the variation
in their ligand interactions is propagated to the back-
bone of these and surrounding residues.
The apo-Ppp5 TPR domain, whether the native se-
quence or the G83N mutant, is substantially unfolded
at physiological temperature, and a helical form is stabi-
lized upon binding to a MEEVD peptide (Cliff et al., 2005).
The solution structure of the peptide bound complex
shows that the ligand achieves widespread stabilization
of the global fold by making contacts with residues in the
first helix of all three of the tetratricopeptide repeats. Be-
cause hydrogen-exchange between backbone amides
of a helix and solvent water takes place on the timescale
of local unfolding of the helix, and because, to a good
approximation, the apodomain undergoes a cooperative
two-state unfolding process (Cliff et al., 2005), the differ-
ential H/D exchange protection seen for different am-
ides in the complex (Figure 4C) reflects the relative sta-
bilization of the local secondary structure due to the
ligand. The data show that this stabilization is unevenly
distributed throughout the structure. The degree of pro-
tection of the most protected amides in a3, and in a2 and
a4 (with which a3 has the most extensive interactions), is
consistent with exchange in these helices occurring only
in the absence of the ligand. In contrast, the other heli-
ces, including a1 and a5, which contain several of the
most conserved residues of the binding site (K32, N36,
R101), are able to locally unfold with the ligand bound.
This retention of binding capability, even in the presence
of local unfolding, highlights the structural versatility
of a recognition mechanism that utilizes multiple salt
bridges.
The Bound Peptide Exchanges between Two
Distinct Conformations
Two complete sets of proton resonances were assigned
for the valine residue in the TOCSY spectra of the proton-
ated peptide bound to (>98%) deuterated protein, and
two resonances were also assigned to the a proton of
the aspartate. The observation of exchange crosspeaks
between the two sets of valine resonances in both
TOCSY and NOESY spectra shows that the doubling of
the signals arises from an intramolecular process. The
simplest explanation is that there are two distinct bound
conformations of the peptide in conformational ex-
change. The signal intensities indicated that these two
conformations are present in approximately equal pop-
ulations (Figure 5A). In one conformation, the methyl
chemical shifts are similar to that of the free peptide,
and, in the other, they are shifted to substantially lower
values, consistent with the ring current effects antici-
pated from the proximity of V-1 to F39 in many of the
structures. Varying the mixing time in the NOESY exper-
iment allows the time dependence of the intensity of
the exchange crosspeaks to be defined, and this is ap-
proximately the relaxation rate constant for the process.
Structure
420Figure 4. Backbone Dynamics of the Ppp5-TPR Domain/Hsp90 Peptide Complex
(A) 1H15N-heteronuclear NOE values, reflecting picosecond to nanosecond motions.
(B) Amide proton linewidths at 500 MHz, reflecting microsecond to millisecond motions. Where the amide peak for a residue is absent, the line-
width is assumed to be large.
(C) Relative hydrogen exchange protection. The dynamic parameters shown in their structural context are colored from blue (less dynamic, slow
exchange) to red (more dynamic, relatively rapid exchange); regions without data (usually proline) are colored green.
(D) Graphical representation of the same data in their sequence context (error bars for NOE are propagated from rms spectral noise and, for line-
widths, are given by the fitting procedure).An exchange rate of 44s21 optimally fits the theoretical
curves (Figure 5B). Only one set of peaks was discern-
able for each of the other protons of the peptide (residues
MEE). These peaks have greater linewidths than, but
similar chemical shifts to, those of the free peptide. To-
gether with the lack of NOEs to this part of the peptide,
this suggests that the MEE residues have no persistent
interaction with the domain. Some of the calculated
structures do, however, show salt bridge interactions
between K40 and K97 and the glutamic acid residues
of the peptide. Of course, in the absence of NOEs, these
transient interactions arise purely through the physicalforces embodied in the refinement forcefield. However,
the possibility that they are realistic is supported by the
observed broadening of the resonances of the lysine’s
protons close to their amino groups, consistent with
the notion that they make a variety of distinct hydrogen
bonded interactions.
Hsp90 and Hsp70 Recognition
by the Ppp5-TPR Domain
The combined evidence from the calculated structures,
dynamics, broadened resonances, exchange spectros-
copy, and earlier thermodynamic studies (Cliff et al.,
Hsp90 Recognition by the Ppp5-TPR Domain
4212005) presents a picture of a mechanism for recognition
of the terminal aspartate and valine residues of Hsp90
that is structurally related to that seen in the Hop-
TPR2A crystal structure, but is of more than 100-fold
greater affinity, yet highly dynamic and less specific. Be-
cause the binding site dynamics cause the loss of signal
intensity, the structures calculated for the peptide are
unlikely to be a precise representation of the real variety
of its conformations, and, consequently, it is not possi-
ble to discern all of the details of the binding modes. In
particular, the absence of any individual signal could
arise from peptide binding or be an intrinsic feature of
the TPR domain itself (e.g., the effects of G83 in the
wild-type). However, the data taken together (NOE,
chemical shift, and signal intensity) suggest that the fol-
lowing is a plausible summary of the binding mecha-
nism. The peptide is held by the two-carboxylate clamp
at all times; there are strong NOEs to the terminal aspar-
tate, hydrogen exchange with solvent and the off rate for
Figure 5. Two Exchanging Conformations of the Bound Peptide
(A) Methyl region of the 100 ms mixing time NOESY spectrum of the
MEEVD pentapeptide bound to the deuterated Ppp5-TPR domain.
Two sets of resonances are seen for each of the valine methyl
groups (g and g*), and these show exchange crosspeaks (marked
g1/g1*, etc.) indicative of two conformations for the bound valine.
(B) Mixing time dependence of the intensities of exchange cross-
peaks (error bars represent rms spectral noise). These data were
fit to a single exponential function, giving a mean rate constant of
44 6 7s21 for the conformational exchange process.the peptide are extremely slow. The clamp is flexible. Al-
ternate hydrogen bonding patterns exist among the
charged and polar residues in the binding site, and these
exchange on the microsecond to millisecond timescale
and give rise to the broadening of signals from many
of the most conserved binding site residues. While the
terminal aspartate is bound, the valine is exchanging be-
tween being bound in an adjacent hydrophobic pocket
or being free of contacts with the protein, evidenced
by two sets of methyl shifts and exchange spectros-
copy. Although transient salt bridges may be made by
the glutamic acid residues at the 22 and 23 positions,
the upstream residues of the peptide lack persistent
contacts with the protein. In the light of this structure,
the diminution of binding of Hsp90 to Ppp5 as a result
of upstream charge-changing mutations (Ramsey
et al., 2000) is most likely explained by reduction in on-
rate due to loss of electrostatic attraction for the positive
binding site. Hsp90 and Hsp70 have the terminal EEVD
sequence in common, and hydrophobic residues up-
stream of these are used by the Hop-TPR domains to
specifically distinguish between the two termini, with
Hop-TPR1 binding Hsp70 and Hop-TPR2A binding
Hsp90 (Scheufler et al., 2000). In contrast, the limited
interactions seen for the high-affinity binding of the
Ppp5-TPR domain provide no obvious means by which
to distinguish Hsp90 and Hsp70. This provides a simple
structural explanation for the recent observation that
Ppp5 interacts with both Hsp70 and Hsp90 in vivo via
its TPR domain (Zeke et al., 2005).
Comparison with Hop and Other Hsp90 Binding
TPR Domains
The NMR structure of the Ppp5-TPR complex with an
MEEVD peptide provides further structural confirmation
of the generality of the two-carboxylate clamp mecha-
nism for recognition of Hsp70/90. However, the Ppp5-
TPR recognition mechanism is distinct in several re-
spects. In principle, some of the differences could be
consequences of the change in environment (solution
versus crystal); however, the main features appear to
correspond well with differences in certain residues
within the binding site. The original Hop-TPR domain
structures, sequence conservation, and mutagenesis
highlighted the primary recognition motif for the Hsp90
binding TPR domains—the two-carboxylate clamp—as
consisting of three positive residues and two small res-
idues capable of acting as both donors or acceptors
(Russell et al., 1999; Scheufler et al., 2000; Brinker
et al., 2002). These polar residues are hydrogen bonded,
both directly and indirectly via water, to the carboxylate
groups of the aspartate and the backbone of the final
three residues. Ppp5 TPR conserves this motif in the
form of K32, N36, N67, K97, and R101 (Figure 3). The
Ppp5 structure also draws attention to the role of a sec-
ondary and largely apolar pocket, which consists of F39,
L70 (which are almost always apolar residues; Figure 6),
and contacts with the CH2 group from the conserved
asparagine side chains (N36, N67). This pocket accom-
modates the peptide’s valine (V-1) in the Hop, CHIP,
and Ppp5 structures, and its reduction by mutation of
the phenylalanine to alanine markedly reduces binding
of Hsp70/90 peptides to Cyp40 (Carrello et al., 2004). A
hydroxyl group of a conserved tyrosine (Y51) at the
Structure
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The color coding of binding site residues corresponds to that of Figure 3; additionally, the residues involved in the semiconserved structural salt
bridges are highlighted in blue and red.base of the pocket gives it a small amount of polar char-
acter, which will weaken the hydrophobic interaction
and may account for mobility of the peptide’s valine in
Ppp5. In the Hop and CHIP structures, interactions
with upstream residues of the peptide apparently cause
it to bind in a fixed conformation. In the Hop domain, ex-
tensive contacts between E-3 and M-4 of the peptide
and the TPR domain result in the peptide lying in an ex-
tended conformation along the third helix. None of the
residues responsible for these contacts is conserved
in the Ppp5 domain. Specifically, in Hop, E-3 makes a hy-
drogen bond from its backbone carbonyl to the hydroxyl
of Y236 (F39 in Ppp5), from its backbone amide to E271
(R74 in Ppp5), and from its side chain carboxylate to
N308 (A104 in Ppp5). The apolar interaction of the methyl
side chain of M-4 with Y236 in Hop (F39 in Ppp5) is pre-
vented in Ppp5 by Y44 occupying that site (shifted by 3 A˚
relative to the position of the equivalent F241 in Hop).
Probably most importantly, the presence of a bulky leu-
cine residue at L70 (instead of the alanine found in Hop)
prevents the peptide lying flat on the domain’s surface.
The collective effect of these changes can be thought tobe the release of the MEE residues of the peptide. CHIP
shares four of these changes from the Hop-TPR2A se-
quence, and its recent structure shows that the peptide
also does not have the Hop conformation. However, in
CHIP, the MEE residues are not released, but are bound
in a U-shaped conformation, because M-4 binds an apo-
lar patch formed by the unusual change of one of the ar-
ginines of the clamp to a phenyalanine (R101 in Ppp5). A
consequence of this conformation is that residues up-
stream of M-4 do not interact with the domain, and
that CHIP is also found to bind both Hsp70 and Hsp90
(Connell et al., 2001).
Sequence comparison shows that the primary posi-
tive clamp and secondary apolar pocket that bind the
terminal VD of the peptide are very highly conserved
among Hsp binding TPR domains, whereas surrounding
residues, which appear to control peptide conformation
and, consequently, aspects of specificity for Hsp90 and
Hsp70 sequences, have greater variety (Figure 6). In-
deed, no two domains have all of these binding site res-
idues in common. However, some similarities can be
seen; FKBP52, 51, and 36, and also Tom34 all have a
Hsp90 Recognition by the Ppp5-TPR Domain
423Figure 7. Implications of the Structure for Re-
lief of Autoinibition of Ppp5
Structures of the Hsp90 peptide bound TPR
domains from Ppp5-TPR and Hop-TPR2A
are superimposed on the structure of the
autoinhibited form of Ppp5. The probable di-
rections of continuation of the Hsp90 poly-
peptide chain are indicated by the dashed
lines. A model based on the Hop structure
suggested direct displacement of the aJ he-
lix, which forms part of the autoinhibitory in-
terface. The actual structure of the Ppp5-
TPR/peptide complex suggests that such
competition does not occur, and that dis-
placement of a7 of the domain as a result of
ligand binding instead disrupts the aJ inter-
action.bulky hydrophobic residue at the position equivalent to
L70, and this would seem to preclude the extended
(Hop-like) conformation for Hsp peptides bound to
these domains. SGTA has an alanine at this position,
which would allow the extended Hop conformation,
but lacks the residues that make contact with E-3 in
Hop. Since these domains do not have the arginine mu-
tation found in CHIP, it is tempting to speculate that they
may share the dynamic features of the recognition
mechanism of Ppp5. In addition to Ppp5 and CHIP, the
TPR domains of TPR2 (Brychzy et al., 2003) and Cyp40
(Carrello et al., 2004) have been reported to bind both
Hsp90 and Hsp70 with similar affinity. These three do-
mains have alanine or threonine at the equivalent posi-
tion to L70 and probably bind the peptide in an extended
conformation; consequently, their minimal discrimina-
tion between Hsp90 and Hsp70 requires another expla-
nation. One possibility is that the change of phenylanine
in the M-4 binding pocket of Hop (Scheufler et al., 2000)
to tyrosine or tryptophan eliminates or reduces this apo-
lar pocket, removing the ability of these domains to dis-
criminate the methionine of Hsp90 from the isoleucine of
Hsp90. Of the other Hsp90 binding domains, the binding
site residues of FKBP38 seem most similar to Hop-
TPR2A and would seem most likely to share its peptide
conformation and binding specificity.
Implications for Relief of Autoinhibition in Ppp5
In the autoinhibited (closed) form of Ppp5, it was found
that the autoinhibitory interface and the Hsp90 binding
site are in close proximity to each other (Yang et al.,
2005). On the basis of the structures of the Hop com-
plexes with terminal peptides from Hsp90 and Hsp70,
in which the peptides lie in an extended conformation,
its was suggested that bound Hsp70 or Hsp90 would oc-
clude the autoinhibitory interface, interfering with the in-
teraction of the phosphatase domain’s terminal aJ helix
with the TPR domain (Figure 7). The structure of the
Ppp5/Hsp90 peptide complex does not support this hy-
pothesis. The variability of the peptide conformation
means that Hsp90 (or Hsp70) can bind without directly
interacting with the autoinhibitory interface (Figure 7).
Instead, superposition of the Ppp5-TPR/MEEVD struc-
ture on the closed form raises the possibility of an allo-
steric mechanism for relief of autoinhibition. In the pep-tide bound conformation, the seventh helix of the TPR
domain is significantly displaced from its position in
the closed structure. In the context of the closed form,
the helix is displaced 3 A˚ toward the terminal aJ helix
and would create steric clashes between their side
chains. Binding of the peptide could thus weaken the
autoinhibitory interface through its effect on the orienta-
tion of the seventh helix, leading to activation of the
enzyme. There are extensive differences between the
autoinhibited and peptide bound structures with re-
spect to the contacts between the final three helices of
the domain. It seems most plausible that the direct ef-
fects of peptide binding upon residues in the fifth helix,
which itself is displaced 2 A˚, are transmitted via these
packing changes to the seventh helix. The most obvious
effects of binding the ligand are the displacement of Y95
(3 A˚), which partially occupies the aspartate binding site
in the absence of peptide, and R101 (2 A˚). Both residues
are absolutely conserved in Ppp5.
Concluding Remarks
A highly dynamic variation on the ‘‘two-carboxylate
clamp’’ mechanism for recognition of the Hsp90 and
Hsp70 C termini by TPR domains has been found for
protein phosphatase 5. The features of this recognition
mechanism, for the TPR-Hsp90 complex with the high-
est reported affinity, will influence models of interaction
of other TPR-containing cochaperones with Hsp90 and
Hsp70. In particular, the interpretation of small differ-
ences in the dissociation constant found by mutagene-
sis of peptide or the TPR domain now seems more am-
biguous. In addition to loss or gain of specific contacts,
changes in binding site or peptide dynamics could make
a significant contribution to affinity, as could changes in
populations of multiple transient hydrogen bonds or to
the average of long-range electrostatic interactions.
The considerable difference in mechanism created by
the small number of differences in the surface residues
between Hop and Ppp5 emphasizes the adaptability
and variety of means by which TPR domains can medi-
ate protein-protein interactions. It will be important
to pursue solution structural and dynamic studies of
other TPR domains to elucidate the extent and role





Residues 19–147 of human Ppp5 were expressed as a His-tagged
fusion protein in pET28m (Novagen). BL21(DE3) pLysS cells were
transformed with this plasmid and grown at 37ºC in minimal M9 me-
dia, containing 15N-Ammonium sulfate and/or 13C-glucose (Cam-
bridge Isotope Laboratories, CIL) as appropriate, and supplemented
with 50 mg/ml kanamycin and 10 mg/ml chloramphenicol. Induction
was by addition of 200 mM IPTG at a cell culture OD of 0.8. Incubation
was continued overnight at 18ºC, prior to harvesting by centrifuga-
tion. Deuteration (w90%) for sequential assignment was achieved
by substituting H2O with > 99% D2O in the media. The G83N muta-
tion was created as described previously (Cliff et al., 2005), and
the domain was expressed as a His-tagged fusion protein from
pQE30 (Qiagen) as described above, except that the antibiotic was
50 mg/ml carbenicillin. In the case of the 2H15N sample, media pre-
pared with D2O and perdeuterated glucose (CIL) were used to
achieve >98% deuteration of nonexchangeable protons.
The His-tagged protein domains were purified from cell lysate by
metal affinity and cation-exchange chromatography in denaturing
conditions and subsequently refolded as described in detail else-
where (Cliff et al., 2005). Samples were prepared for NMR by dialysis
against a buffer solution of 50 mM MES (pH 6.0), 5 mM DTT, followed
by concentration in the presence of a slight excess (initial concentra-
tion) of peptide. The peptide MEEVD was synthesized in an N-termi-
nally acetylated form by Peptide Protein Research, and purity was
checked by HPLC and mass spectrometry. The peptide was sup-
plied as a certified 1 mg/ml aqueous solution. All chemicals were ob-
tained from Sigma, except when otherwise stated.
NMR Spectroscopy and Sequential Assignment
All NMR spectra were recorded by using 0.5–1.2 mM protein in the
standard buffer conditions to which was added 5% D2O (unless oth-
erwise stated) at 25ºC on Varian Unity Plus 500 MHz or Varian Inova
600 MHz or 800 MHz spectrometers. Spectra were processed by us-
ing NMRPipe/NMRDraw (Delaglio et al., 1995) and were analyzed
with Ansig (Kraulis, 1989).
The backbone of the native domain was assigned by using the
standard triple resonance experiments (Yamazuki et al., 1994) and
2H13C15N-labeled protein. The assignments of the 1H15N-HSQC
spectra of G83N and wild-type domains were shown to be almost
identical through comparison of HNCA, CBCACONH, and CBCA
(CO)NH spectra recorded by using 13C15N-labeled protein. The as-
signment was confirmed and extended by 15N-edited TOWNY-
HSQC and NOESY-HSQC spectra recorded by using a 15N-labeled
sample. The side chains of the mutant protein were assigned by us-
ing the above-mentioned spectra plus HNHB, 1H13C-HCCH-TOCSY-
HSQC (40 ms and 120 ms mixing times, 600 MHz), and 1H13C-
NOESY-HSQC (120 ms mixing time, 800 MHz) spectra recorded by
using a 13C15N-labeled sample in 95% D2O. The assignment of the
proton resonances of the peptide was based on the 1H-TOCSY
and 1H-NOESY spectra of the 300 mM protonated peptide in the
presence of a slight excess of 2H15N-labeled G83N mutant protein
in both D2O and H2O. In addition, a natural abundance
1H13C-
HSQC was recorded in D2O. In these samples, the MES buffer and
DTT were included in perdeuterated form (CIL).
Structure Determination
Chemical shift lists for the G83N mutant protein were prepared from
the assigned protein HSQCs and peptide spectra. Crosspeaks for
the 15N- and 13C-edited NOESY spectra were picked semiautomat-
ically in Ansig, by using in-house scripts that restrict crosspeak
chemical shifts to values in the shift lists. Spectra were checked
manually to ensure that all significant NOESY intensity was ac-
counted for by crosspeaks. Several rounds of structure calculations
were performed with ARIA v1.2 (Linge et al., 2001). In each round, the
default ARIA settings were used, except that the ‘‘Q-exclude’’ func-
tion was switched off and instead potential artifactual peaks causing
restraint violations were identified by inspection of the spectra. The
Aria input consisted of the NOESY crosspeaks, as well as backbone
angle restraints derived from Ca, Cb, C0, HN, and Ha chemical shift
data by using the program TALOS (Cornilescu et al., 1999). Structure
calculations used the PARALLHDG5.3 parameters with PROLSQnonbonded interactions (Linge et al., 2003). Floating chirality assign-
ments were used throughout for all methylene and isopropyl pro-
tons. Hydrogen bond restraints were introduced cautiously following
inspection of amide hydrogen exchange protection data and/or
intermediate structures. The final restraints are detailed in Table 1.
In the final iteration, 100 structures underwent refinement in water
(Linge et al. 2003), and the 19 structures with the lowest NOE energy
were selected for statistical analysis. All structural illustrations were
created with PyMol (DeLano, 2002; http://www.pymol.org).
Relaxation Measurements, Linewidths, and H/D Exchange
The 1H15N-NOE data were recorded at 25ºC with a 15N-labeled sam-
ple of the G83N mutant protein at 600 MHz by using standard pulse
sequences (Barbato et al., 1992). Proton linewidths were extracted
from a 1H15N-HSQC spectrum of a 15N-labeled protein sample re-
corded on the 500 MHz spectrometer (because some resonances
broaden with increasing field, this low field gave the most informa-
tion) by using the nlinLS function of NMRPipe. Amide hydrogen ex-
change protection data were determined fortuitously, as the sample
used for recording 1H13C-3D spectra was not fully exchanged after
3 weeks at 4ºC, and are given as the ratio of signal intensities
between the 1H15N-HSQC of this sample and an equivalent 1H15N-
HSQC recorded in H2O.
Exchange Spectroscopy
Two conformations of the bound peptide were clearly distinguish-
able and gave exchange crosspeaks in the 2D TOCSY and NOESY
experiments performed on the protonated peptide in the presence
of excess 2H15N G83N mutant protein. To obtain the rate constant
for the exchange process, the NOESY experiment was repeated at
4 mixing times, 20 ms, 40 ms, 100 ms, and 120 ms. The intensities
of the crosspeaks depend on the mixing time according to the rela-
tionship:
IABðtmÞ = MBo:=2: ½1 + expf2 ðk1 + k2 1Þ:tmg:expf2 tm=T1g
IBAðtmÞ = MAo:=2: ½12 expf2 ðk1 + k2 1Þ:tmg:expf2 tm=T1g
where Mi is the maximum magnetization of species i, tm is the mixing
time, k1 and k21 are the rate constants for the forward and reverse
reactions, respectively, and T1 is the longitudinal relaxation time (af-
ter Chapter 9 of Ernst et al., 1987). In the case where k1 + k21 > > 1/T1
and tm < < T1, this approximates to IAB(tm) = MBo./2. [exp {2(k1 +
k21).tm}]. The intensities for the exchange or NOE crosspeaks
were fit to this single exponential function by using Origin 5.0
(Microcal).
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